| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Cefpodoxime | Cefpodoxime Proxetil Dimer Impurity | VE0015846 | View |
| Cefpodoxime | Cefpodoxime Proxetil EP Impurity A | VL1830001 | View CAS 80210-62-4 |
| Cefpodoxime | Cefpodoxime Proxetil EP Impurity D | VE0011529 | View CAS 947692-13-9 |
| Cefpodoxime | Cefpodoxime Proxetil EP Impurity H | VL1830002 | View CAS 947692-16-2 |
[rfq_list]
| Catalogue No. | VL1830001 |
| CAS No. | 80210-62-4 |
| Molecular Formula | C₁₅H₁₇N₅O₆S₂ |
| Molecular Weight | 427.46 |
| Parent drug | Cefpodoxime |
| IUPAC Name | (6R, 7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; |
| Synonyms | Cefpodoxime Acid Impurity |
| References | Sci-Hub, An improved method for preparation of cefpodoxime proxetil, 10.1016/s0014-827x(03)00051-x. (2022). Retrieved January 12, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/s0014-827x(03)00051-x |
| Status | In-stock |
| ListName | Cefpodoxime Proxetil EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
